J. Goldman & Co LP - PTC THERAPEUTICS INC ownership

PTC THERAPEUTICS INC's ticker is PTCT and the CUSIP is 69366J200. A total of 128 filers reported holding PTC THERAPEUTICS INC in Q4 2016. The put-call ratio across all filers is 0.54 and the average weighting 0.2%.

Quarter-by-quarter ownership
J. Goldman & Co LP ownership history of PTC THERAPEUTICS INC
ValueSharesWeighting
Q4 2017$10,897,000
+541.4%
653,284
+669.7%
0.57%
+565.1%
Q3 2017$1,699,000
-56.8%
84,880
-60.4%
0.09%
-59.6%
Q2 2017$3,930,000
-73.2%
214,380
-85.6%
0.21%
-70.7%
Q1 2017$14,678,000
+1823.7%
1,491,722
+2032.6%
0.73%
+1323.5%
Q4 2016$763,000
+19.8%
69,950
+568.4%
0.05%
+30.8%
Q1 2015$637,00010,4660.04%
Other shareholders
PTC THERAPEUTICS INC shareholders Q4 2016
NameSharesValueWeighting ↓
Boxer Capital, LLC 2,155,000$101,285,00011.24%
RTW INVESTMENTS, LP 3,275,591$153,953,0009.22%
Asymmetry Capital Management, L.P. 173,010$8,131,0007.51%
GREAT POINT PARTNERS LLC 717,458$33,721,0005.26%
Ghost Tree Capital, LLC 500,000$23,500,0005.00%
MAK CAPITAL ONE LLC 221,723$10,421,0003.41%
Opaleye Management Inc. 180,000$8,460,0002.15%
Avoro Capital Advisors LLC 684,000$32,148,0001.48%
SCOPIA CAPITAL MANAGEMENT LP 1,616,998$75,999,0001.46%
SPHERA FUNDS MANAGEMENT LTD. 210,000$9,870,0001.13%
View complete list of PTC THERAPEUTICS INC shareholders